Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-23

Clinical Trial Update: Have Malaria Infections in Kenya Become Less Responsive to Artemisinin Treatment? [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating whether malaria infections in Kenya have become less responsive to artemisinin-based therapy; the trial status is currently unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin-based combination therapy (ACT)

Snippet

Sponsor: KEMRI-Wellcome Trust Collaborative Research Program | Conditions: Malaria | Phase 4 | Status: UNKNOWN